Abstract
This chapter describes two medications that were approved for the treatment of obesity in the 20th century. The first is phentermine, one of the sympathomimetic drugs that were approved between 1959 and 1973 all of which are scheduled drugs according to the U.S. Drug Enforcement Agency. They mimic the effects of the sympathetic nervous system, and thus their names. Phentermine is the most widely used anti-obesity drug but is approved for only a few weeks. However, it is often used off-label for extended periods of time. The safety and efficacy of phentermine at half the dose approved for short-term use has been approved for long-term use in combination with topiramate. Orlistat (Xenical) is not a scheduled drug and is approved for long-term use in more countries than any other drug. It works by blocking intestinal lipase and can thus produce gastro-intestinal side-effects. The drug produces modest weight loss and is available by prescription, and in some countries without a prescription at half the prescription dose. New data shows that orlistat used as a mouthwash decreases fat food intake in people that eat more and presumably prefer fat. An orlistat mouthwash would eliminate the gastrointestinal side effects of oral orlistat.